Almitrine-Raubasine Combination (Duxil) for Dementia

Abstract

This systematic review investigated almitrine-raubasine combination (brand name Duxil) as an alternative treatment for dementia.

There was insufficient evidence to support the routine use of Duxil for the treatment of patients with dementia, due to the low methodological quality of trials available so far, the small number of these trials and their probable publication bias. High-quality and large-scale randomised controlled trials are needed.

Full Text Link

Reference

Yang, W. Liu, M. [and] Teng, J. [et al] (2011). Almitrine-Raubasine combination for dementia. Cochrane Database of Systematic Reviews (Online), March 16th 2011, Issue No.3, No.CD008068. (Click here to view the PubMed abstract).

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in For Researchers (mostly), International, Pharmacological Treatments, Systematic Reviews, Universal Interest and tagged , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.